Aarti Drugs Ltd.

AARTIDRUGS

₹402.75

-3.59% (-15.0)

Market Cap

₹3,811 Cr.

P/E

22.66

About

Aarti Drugs Limited, established in 1984, is part of Aarti Group of Industries with a strong R&D Division in Maharashtra. The company manufactures APIs, Pharma Intermediates, Specialty Chemicals, and … Read more

Aarti Drugs Limited, established in 1984, is part of Aarti Group of Industries with a strong R… Read more

Low

312

52W Range

High

635

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

APIs Production Capacity (MTPA)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Nizoral

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Customers

Abbott India Ltd.
Alembic Pharmaceuticals Ltd.
Cipla Ltd.
Indoco Remedies Ltd.
Kopran Ltd.
Lupin Ltd.
Pfizer Ltd.
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Zydus Wellness Ltd.
Alkem Laboratories Ltd.
Intas Pharma
Mankind Pharma
Micro Labs Limited
Laborate Pharmaceuticals India Ltd.
MEDESY INTERNATIONAL
Sanofi India Ltd.

Showing 5 of 17

FAQs on Aarti Drugs Ltd. Business

What does Aarti Drugs do?

Aarti Drugs Limited, a key player in the pharmaceutical industry, specializes in manufacturing APIs, Pharma Intermediates, Specialty Chemicals, and Formulations including Ciprofloxacin Hydrochloride and Metronidazole.

Who are the competitors of Aarti Drugs?

Aarti Drugs major competitors are Morepen Laboratories, Supriya Lifescience, Solara Active Pharma, SMS Pharmaceuticals, IOL Chem & Pharma, Bajaj Healthcare, Hester Biosciences.
Market Cap of Aarti Drugs is ₹3,811 Crs.
While the median market cap of its peers are ₹2,140 Crs.

Is Aarti Drugs financially stable compared to its competitors?

Aarti Drugs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep
Investor Presentation	May	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar May Jun Jul Aug Sep Dec	Jan Mar Jun Sep Dec	Mar Jun Sep Dec	Mar	Jun Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec		Sep
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Aarti Drugs Ltd.

View the discussion on ValuePickr

AARTI DRUGS vs AARTI PHARMALABS | Which is Best? - Value Educator

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Aarti Drugs Ltd.